GO:0006998 nuclear envelope organization: Components, Assembly and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0006998 nuclear envelope organization describes the assembly, arrangement, and disassembly of the nuclear envelope, the double membrane that separates the nucleus from the cytoplasm.
The nuclear envelope is not a static barrier; it connects structural genome organization to the regulation of gene expression.
Chromosome-nuclear envelope attachments are critical for 3D genome organization and are conserved across eukaryotes.
Disruption of nuclear envelope organization is linked to human diseases including laminopathies, cancer, and parasitic infections.
Key proteins include lamins, lamin-associated proteins, and nuclear pore complex components that mediate membrane remodeling and chromatin tethering.
CRISPR-based knockout, knock-in, and overexpression models enable causal testing of nuclear envelope organization genes in disease and development.

Description

The nuclear envelope (NE) is a specialized double-membrane structure that encloses the eukaryotic nucleus and organizes the boundary between nuclear and cytoplasmic compartments. GO:0006998 nuclear envelope organization is the biological process that carries out the assembly, arrangement of constituent parts, and disassembly of this envelope at the cellular level. This process is fundamental not only for maintaining nuclear architecture but also for connecting structural genome organization to the regulation of gene expression. Research over the past decades has revealed that the NE is a dynamic hub that anchors chromatin, regulates gene activity, and participates in cell cycle progression and differentiation. Understanding nuclear envelope organization is essential because defects in this process underlie a growing list of human disorders, including laminopathies, cancer, and diseases caused by parasitic protozoa. The NE also plays a central role in genome stability, as its breakdown and reassembly during mitosis must be tightly coordinated with chromosome segregation. Moreover, chromosome-NE attachments contribute to the spatial organization of the genome, influencing transcriptional programs and DNA repair. This article provides a research-grade overview of GO:0006998, covering its definition, molecular components, regulatory mechanisms, disease relevance, and experimental strategies. It is intended for researchers seeking to study nuclear envelope organization using CRISPR-based models and functional genomics approaches.

nuclear envelope organization At A Glance

GO ID GO:0006998
GO term nuclear envelope organization
Ontology biological_process
Synonym nuclear envelope organisation; nuclear envelope organization and biogenesis
Major function Assembly, arrangement, and disassembly of the nuclear envelope
Cellular location Nuclear envelope
Related processes Nuclear envelope disassembly, nuclear envelope reassembly, nuclear pore complex assembly
Key proteins Lamins, lamin-associated proteins, nuclear pore complex components
Disease relevance Laminopathies, cancer, parasitic infections

What Is GO:0006998?

GO:0006998 nuclear envelope organization is defined as a process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the nuclear envelope. In other words, it encompasses all cellular activities that build, rearrange, or break down the double membrane surrounding the nucleus, including the inner and outer nuclear membranes, nuclear pore complexes, and their associated protein networks.

Why Is nuclear envelope organization Important in Cell Biology?

Nuclear envelope organization is important because the nuclear envelope is not merely a passive barrier but an active regulator of genome organization, gene expression, and cell division. Defects in this process can lead to misregulation of chromatin architecture, genomic instability, and a range of human diseases, including muscular dystrophies, premature aging syndromes, and cancer. In parasitic protozoa, specialized nuclear envelope organization is associated with disease pathogenesis, making it a potential therapeutic target. Furthermore, understanding how the NE assembles and disassembles is critical for basic cell biology, as it intersects with the cell cycle, nuclear transport, and mechanotransduction.
Maintains nuclear-cytoplasmic compartmentalization, essential for eukaryotic cell function.
Connects structural genome organization to the regulation of gene expression.
Facilitates chromosome-nuclear envelope attachments that shape 3D genome organization.
Its disassembly and reassembly are coordinated with mitosis and cell cycle progression.
Mutations in NE proteins cause laminopathies and other genetic disorders.
Altered NE organization is observed in many cancers and contributes to tumorigenesis.
In parasitic protozoa, NE specializations are linked to disease and immune evasion.
Provides a model for studying membrane remodeling and protein targeting.
Serves as a platform for CRISPR screens to identify regulators of nuclear architecture.
Relevant to aging research, as NE defects are associated with premature aging.

What Happens During nuclear envelope organization?

Nuclear envelope assembly
In simple terms: The cell builds a new nuclear envelope around the chromosomes after cell division.
During nuclear envelope assembly, membrane vesicles derived from the endoplasmic reticulum fuse around chromatin to form the inner and outer nuclear membranes. This process requires the recruitment of specific proteins, including lamins and nuclear pore complex components, which are targeted to chromatin in a regulated manner. In organisms such as Dictyostelium discoideum, nuclear envelope organization involves dynamic changes in membrane and protein composition during the cell cycle.
Nuclear envelope disassembly
In simple terms: The nuclear envelope breaks down to allow chromosome segregation during mitosis.
Nuclear envelope disassembly occurs at the onset of mitosis, when the nuclear membranes are phosphorylated and fragmented, and nuclear pore complexes are disassembled. This step is essential for allowing spindle microtubules to access chromosomes. The breakdown is tightly regulated by mitotic kinases, and defects can lead to chromosome missegregation and genomic instability.
Chromatin tethering and genome organization
In simple terms: The nuclear envelope anchors chromosomes to specific regions, helping organize the genome.
The nuclear envelope provides attachment sites for chromosomes, which are mediated by proteins such as lamins and inner nuclear membrane proteins. These attachments influence the spatial organization of the genome, bringing specific genomic regions to the nuclear periphery where they can be transcriptionally repressed or activated. Chromosome-NE attachments are conserved across eukaryotes and are important for gene regulation and DNA repair.
Nuclear pore complex assembly and distribution
In simple terms: The nuclear envelope contains pores that control what enters and exits the nucleus.
Nuclear pore complexes (NPCs) are large protein channels embedded in the nuclear envelope that mediate nucleocytoplasmic transport. During nuclear envelope organization, NPCs are assembled and distributed within the membrane, a process that requires the coordinated action of nucleoporins and membrane remodeling factors. Proper NPC organization is essential for nuclear transport and gene expression regulation.
Nuclear envelope in parasitic protozoa
In simple terms: Some parasites have special nuclear envelope features that help them cause disease.
In parasitic protozoa, the nuclear envelope exhibits specialized organization that is associated with disease pathogenesis. These specializations include unique chromatin-NE interactions and stage-specific nuclear envelope remodeling that contribute to immune evasion and parasite survival. Studying these processes can reveal new drug targets.

Key Genes Involved in GO:0006998 nuclear envelope organization

The following genes and proteins are central to nuclear envelope organization, based on published literature.
GeneMajor RoleResearch Relevance
LMNA Encodes lamin A/C, a key structural component of the nuclear lamina Mutations cause laminopathies; studied in aging and cancer
LMNB1 Encodes lamin B1, involved in nuclear envelope integrity Altered in cancer and neurodegeneration
LMNB2 Encodes lamin B2, contributes to nuclear lamina structure Linked to lipodystrophy and brain disorders
EMD Encodes emerin, an inner nuclear membrane protein Mutations cause Emery-Dreifuss muscular dystrophy
LBR Lamin B receptor, connects lamina to chromatin Involved in chromatin organization and nuclear envelope assembly
NUP153 Nuclear pore complex component Regulates chromatin organization and gene expression
NUP98 Nuclear pore complex component Frequently rearranged in leukemia
SUN1 Inner nuclear membrane protein linking nucleoskeleton to cytoskeleton Important for chromosome tethering and genome organization
SUN2 Inner nuclear membrane protein, similar to SUN1 Involved in nuclear positioning and meiosis
SYNE1 Outer nuclear membrane protein, links NE to cytoskeleton Mutations cause muscular dystrophy and cerebellar ataxia
SYNE2 Outer nuclear membrane protein, interacts with SUN proteins Linked to muscular dystrophy and cancer
BANF1 Barrier-to-autointegration factor, involved in NE reassembly Mutations cause progeroid syndrome
LEM2 Inner nuclear membrane protein, binds BAF and lamins Regulates NE assembly and chromatin decondensation
CHMP7 ESCRT-III component involved in NE sealing Required for nuclear envelope reformation
VPS4 AAA-ATPase that regulates ESCRT-III disassembly Plays a role in NE remodeling
RANBP2 Nuclear pore complex component and SUMO E3 ligase Regulates NE assembly and chromosome segregation
NUP107 Nuclear pore complex component Essential for NPC assembly and function
NUP62 Nuclear pore complex component Involved in nucleocytoplasmic transport

How Is nuclear envelope organization Regulated?

Nuclear envelope organization is regulated by cell cycle-dependent phosphorylation events, particularly by cyclin-dependent kinase 1 (CDK1), which phosphorylates lamins and nuclear pore complex proteins to trigger disassembly at mitosis. Reassembly is regulated by dephosphorylation and the action of the ESCRT-III machinery, which seals the nuclear envelope after chromosome segregation. Additionally, small GTPases such as Ran regulate nucleocytoplasmic transport and NE assembly. In parasitic protozoa, stage-specific regulation of NE organization is linked to differentiation and disease progression.

nuclear envelope organization and Human Disease

GeneDisease / BiologyPotential Experimental Model
LMNAHutchinson-Gilford progeria syndrome, muscular dystrophyKnock-in mouse models, patient-derived iPSCs
EMDEmery-Dreifuss muscular dystrophyKnockout mice, CRISPR-corrected iPSCs
SYNE1Cerebellar ataxia, muscular dystrophyKnockout zebrafish, mouse models
NUP98LeukemiaKnock-in fusion models, CRISPR screens
BANF1Progeroid syndromePoint-mutation knock-in mice
Laminopathies and premature aging
Mutations in LMNA and other nuclear envelope genes cause a spectrum of diseases known as laminopathies, including Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, and Hutchinson-Gilford progeria syndrome. These disorders are characterized by defects in nuclear envelope organization, leading to altered chromatin organization and gene expression. Studies have shown that disrupted NE organization contributes to premature aging and tissue-specific degeneration.
Cancer
Alterations in nuclear envelope organization are frequently observed in cancer cells, where they contribute to genomic instability and altered gene expression. For example, changes in lamin expression and nuclear pore complex composition are associated with tumor progression and metastasis. The NE also influences chromatin organization, which can affect oncogene and tumor suppressor gene expression.
Parasitic infections
In parasitic protozoa, specialized nuclear envelope organization is associated with disease pathogenesis. These organisms exhibit unique NE specializations that facilitate immune evasion and adaptation to host environments. Targeting these NE-specific processes could lead to new antiparasitic therapies.
Neurodegeneration
Defects in nuclear envelope organization have been linked to neurodegenerative diseases, including ataxia and neuropathy. Mutations in SYNE1 and SYNE2, which encode NE proteins, are associated with cerebellar ataxia and muscular dystrophy. Understanding how NE organization affects neuronal function may reveal new therapeutic targets.

From nuclear envelope organization-Related Genes to Experimental Models

Research QuestionSuitable Model
What is the role of LMNA in nuclear envelope organization?LMNA knockout cell lines and mice
How do point mutations in EMD affect NE integrity?EMD point-mutation knock-in models
Can overexpression of LMNB1 rescue NE defects?LMNB1 overexpression cell lines
What is the function of SUN1 in chromosome tethering?SUN1 knockout and tagged knock-in cells
How does NUP98 fusion affect nuclear pore organization?NUP98 knock-in leukemia models
What genes regulate NE reassembly?Genome-wide CRISPR knockout screens

How to Study the nuclear envelope organization Process

MethodWhat It MeasuresTypical Application
Fluorescence microscopyNuclear envelope morphology and protein localizationAssessing NE integrity in cells
Live-cell imagingDynamics of NE assembly and disassemblyMitosis studies
Electron microscopyUltrastructure of nuclear envelopeDetailed membrane analysis
ChIP-seqChromatin-NE interactionsMapping genome organization
Hi-C3D genome organizationChromosome tethering studies
ProteomicsNE protein compositionIdentifying novel NE components
CRISPR screensGenes required for NE organizationFunctional genomics
RNA-seqGene expression changesTranscriptional consequences of NE disruption
Imaging-based methods
Fluorescence microscopy and live-cell imaging are widely used to visualize nuclear envelope dynamics, including assembly and disassembly during mitosis. Immunostaining for lamins and nuclear pore complex proteins allows assessment of NE integrity and organization. Electron microscopy provides ultrastructural details of nuclear envelope morphology.
Genomic and proteomic approaches
Chromatin immunoprecipitation (ChIP) and Hi-C can map chromosome-NE interactions and 3D genome organization. Proteomics of nuclear envelope fractions identifies components and their post-translational modifications. RNA-seq and Ribo-seq can reveal gene expression changes upon NE disruption.
CRISPR screens
Genome-wide CRISPR knockout screens have been used to identify genes required for nuclear envelope organization and NE reassembly. These screens can uncover novel regulators and potential therapeutic targets. Follow-up validation using focused libraries and imaging-based assays is common.
Biochemical assays
In vitro membrane fusion assays and nuclear assembly extracts from Xenopus eggs have been used to dissect the biochemical steps of NE assembly. These systems allow controlled manipulation of components and identification of essential factors.

How CRISPR Can Be Used to Study GO:0006998 nuclear envelope organization

Knockout

CRISPR knockout of nuclear envelope genes such as LMNA, EMD, or SUN1 allows researchers to study loss-of-function phenotypes, including NE fragility, altered chromatin organization, and cell cycle defects. Knockout cell lines are valuable for dissecting the role of individual components in NE organization.

Point Mutation

Point mutations in NE genes, such as those found in laminopathies, can be introduced using CRISPR base editing or homology-directed repair to model disease-associated variants. These models help determine whether specific mutations are causal for NE defects and disease phenotypes.

Knock-in

Knock-in of tagged versions of NE proteins (e.g., GFP-LMNA) enables live-cell imaging and proteomic analysis of NE dynamics. Knock-in of disease-associated fusion genes, such as NUP98 fusions, can model leukemia and study NE reorganization.

Overexpression

Overexpression of NE proteins, such as LMNB1 or SUN1, can be used to test gain-of-function effects on NE organization and genome architecture. Overexpression models are useful for rescue experiments and for studying dosage effects.

How EDITGENE Supports nuclear envelope organization Research

Researchers studying nuclear envelope organization-related genes often need to determine whether a candidate gene is causally involved in NE assembly, disassembly, or disease. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as library screening and bioinformatics support, enabling rigorous functional studies of GO:0006998.
Contact EDITGENE today to design your custom CRISPR model for nuclear envelope organization research.

Related Products

Product name Cat.No. Species Gene ID
LMNA Knockout HEK293 Cell Line EDJ-KQ1983 Human 4000 Details Get a Quote
TOR1A Knockout HEK293 Cell Line EDJ-KQ2038 Human 1861 Details Get a Quote
LMNB1 Knockout HEK293 Cell Line EDJ-KQ3043 Human 4001 Details Get a Quote
REEP4 Knockout HEK293 Cell Line EDJ-KQ3229 Human 80346 Details Get a Quote
DES Knockout HEK293 Cell Line EDJ-KQ3759 Human 1674 Details Get a Quote
ZMPSTE24 Knockout HEK293 Cell Line EDJ-KQ6983 Human 10269 Details Get a Quote
TMEM170A Knockout HEK293 Cell Line EDJ-KQ8569 Human 124491 Details Get a Quote
REEP3 Knockout HEK293 Cell Line EDJ-KQ8791 Human 221035 Details Get a Quote
LMNB2 Knockout HEK293 Cell Line EDJ-KQ10212 Human 84823 Details Get a Quote
TMEM201 Knockout HEK293 Cell Line EDJ-KQ11710 Human 199953 Details Get a Quote
LMNA Knockout HCT 116 Cell Line EDJ-KQ21960 Human 4000 Details Get a Quote
LMNA Knockout HeLa Cell Line EDJ-KQ21961 Human 4000 Details Get a Quote
TOR1A Knockout A-549 Cell Line EDJ-KQ22079 Human 1861 Details Get a Quote
TOR1A Knockout HCT 116 Cell Line EDJ-KQ22080 Human 1861 Details Get a Quote
TOR1A Knockout HeLa Cell Line EDJ-KQ22081 Human 1861 Details Get a Quote
Displaying Records 1 To 15 Of 48 Records

Frequently Asked Questions About nuclear envelope organization

GO:0006998 is a biological process term describing the assembly, arrangement, and disassembly of the nuclear envelope at the cellular level.
Key genes include LMNA, LMNB1, EMD, LBR, SUN1, SUN2, SYNE1, SYNE2, BANF1, and nuclear pore complex genes such as NUP153 and NUP98.
It maintains nuclear compartmentalization, regulates genome organization and gene expression, and its disruption causes diseases such as laminopathies and cancer.
Common methods include fluorescence microscopy, live-cell imaging, electron microscopy, ChIP-seq, Hi-C, proteomics, and CRISPR screens.
Laminopathies, muscular dystrophies, premature aging syndromes, cancer, and parasitic infections are linked to defects in NE organization.
Lamins form the nuclear lamina, a structural meshwork that supports the NE and anchors chromatin, and their disruption leads to NE instability.
CRISPR knockouts of NE genes allow researchers to observe loss-of-function phenotypes such as NE fragility and altered chromatin organization.
Yes, understanding NE organization may lead to therapies for laminopathies and parasitic diseases, though clinical applications are still under investigation.
The NE provides attachment sites for chromosomes, influencing 3D genome organization and gene expression.
Dictyostelium discoideum, Xenopus, mice, and human cell lines are commonly used.

Conclusion

GO:0006998 nuclear envelope organization is a fundamental biological process that governs the assembly, arrangement, and disassembly of the nuclear envelope, with critical roles in genome organization, gene expression, and cell division. Its dysfunction is linked to a wide range of human diseases, including laminopathies, cancer, and parasitic infections. Advances in CRISPR-based models and functional genomics are accelerating the discovery of new regulators and therapeutic targets in this field. Continued research into nuclear envelope organization will deepen our understanding of nuclear architecture and its impact on health and disease.

References

  1. 1. Batsios P et al.. 2019. Nuclear envelope organization in Dictyostelium discoideum.. Int J Dev Biol 63(8-9-10):509-519 PMID: 31840788
  2. 2. Stancheva I et al.. 2014. Nuclear envelope: connecting structural genome organization to regulation of gene expression.. Adv Exp Med Biol 773:209-44 PMID: 24563350
  3. 3. Sharakhov IV et al.. 2018. The Role of Chromosome-Nuclear Envelope Attachments in 3D Genome Organization.. Biochemistry (Mosc) 83(4):350-358 PMID: 29626922
  4. 4. Ellis JA et al.. 2011. Nuclear envelope disease and chromatin organization.. Biochem Soc Trans 39(6):1683-6 PMID: 22103507
  5. 5. Mekhail K et al.. 2010. The nuclear envelope in genome organization, expression and stability.. Nat Rev Mol Cell Biol 11(5):317-28 PMID: 20414256
  6. 6. Gerace L et al.. 1988. Functional organization of the nuclear envelope.. Annu Rev Cell Biol 4:335-74 PMID: 2461721
  7. 7. Goldberg MW et al.. 1995. Structural and functional organization of the nuclear envelope.. Curr Opin Cell Biol 7(3):301-9 PMID: 7662358
  8. 8. Obado SO et al.. 2016. The nuclear envelope and gene organization in parasitic protozoa: Specializations associated with disease.. Mol Biochem Parasitol 209(1-2):104-113 PMID: 27475118
Contact Us
*
*
*
*
How did you hear about us: